Holen Sie sich die Stockscreener-App
0.34
0.59%
0.002
Vorhandelsmarkt:
.34
Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss and Positive SurpriseBalance Sheet Strength - newsline.com
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Per ShareBook Value Growth - newsline.com
SpaceX Shares Surge 11% in Nasdaq Debut After Landmark $75 Billion IPOPreliminary Results - newsline.com
NASA’s experimental quiet supersonic plane passes another critical milestone - Scientific American
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherROA Comparison - newsline.com
Milestone Scientific (MLSS) asks shareholders to expand share authorization and equity plan - Stock Titan
[EFFECT] MILESTONE SCIENTIFIC INC. SEC Filing - Stock Titan
World Dental Anesthesia Delivery SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Milestone Scientific (MLSS) registers 15.9M shares; warrants exercisable at $0.3375 - Stock Titan
Milestone Scientific (MLSS) asks shareholders to increase authorized shares and equity plan - Stock Titan
DiagnosTear Achieves Major Scientific Milestone with Publication of TeaRx(TM) Clinical Study in Current Eye Research Journal - TMX Newsfile
Milestone Scientific approves stock option repricing and new performance-based awards - Investing.com
MLSS: Selling Stockholder to Offer Nearly 8 Million Shares - GuruFocus
Milestone Scientific (NYSE American: MLSS) registers 15.9M shares from April 2026 placement - Stock Titan
Amazon Stock Could Reach $300 This Year: Key Drivers from Yahoo Finance AnalysisConsensus Beat Rate - The Legal Advocate
Japan hits 6G key milestone with high-frequency speeds topping 100 Gbps - Live Science
Milestone Scientific (MLSS) Rallies 3.9% as Shares Approach Key Resistance at $0.42Calendar Spread Trade - newsline.com
Milestone Scientific’s CompuFlo® Technology Sees Increased Physician Adoption Due to Real-Time Pressure Sensing - geneonline.com
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures - The Manila Times
Milestone Scientific Inc. Reports Increased Adoption of CompuFlo® Epidural System Following Positive Research Findings from University of Texas Medical Branch - Quiver Quantitative
Epidural-guiding device cuts SCS complications by 91% in UTMB study - Stock Titan
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments - Business Wire
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower Loss Beats Estimates as Stock Edges LowerOpen Signal Network - Newser
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss Per ShareDividend Growth Analysis - newsline.com
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss as Commercial Efforts ContinueEarnings Revision Downgrade - The Legal Advocate
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Focuses on Pipeline Development - The Legal Advocate
Benchmark reiterates Milestone Scientific stock rating on revenue guidance By Investing.com - Investing.com Nigeria
Benchmark reiterates Milestone Scientific stock rating on revenue guidance - Investing.com
Milestone Scientific (MLSS) price target decreased by 50.00% to 1.02 - MSN
Milestone Scientific (MLSS) Up +1.01% — Is There More Room to Run? 2026-05-18Volume Climax - The Legal Advocate
Milestone Scientific, Inc. Common Stock (NY: MLSS - FinancialContent
Thermo Fisher Deepens Oncology Role With Ibtrozi Manufacturing Milestone - Yahoo Finance
Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1 - Moomoo
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global Challenges - GuruFocus
Milestone Scientific Earnings Call Signals Cautious Upswing - TipRanks
Milestone Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2026 Earnings Conference - Moomoo
MLSS Projects Strong Revenue Growth Through 2026 - GuruFocus
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations - Investing.com
Milestone Scientific (MLSS) Reports Q1 Revenue Challenges with P - GuruFocus
Full Transcript: Milestone Scientific Q1 2026 Earnings Call - Benzinga
Milestone Scientific stock surges 9% on narrower loss By Investing.com - Investing.com South Africa
Milestone Scientific Q1 revenue steady, operating loss narrows - TradingView
Milestone Scientific stock surges 9% on narrower loss - Investing.com UK
Milestone Scientific Reports Financial Results for First Quarter 2026 - marketscreener.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Milestone Scientific (MLSS) trims Q1 2026 loss but flags going concern and NYSE listing risks - Stock Titan
Earnings call transcript: Core Scientific Q1 2026 reveals mixed performance - Investing.com
TradingKey - TradingKey
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call - Moomoo
Milestone Scientific will discuss Q1 results and business update May 14 - Stock Titan
Doctors in 7 states begin epidural procedures with CompuFlo - Stock Titan
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption - The Manila Times
1.68%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):